Objective: This study was designed to compare the sensitivity, specificity, efficiency, positive and negative predictive values, and ease of use for 2 commercially available hybridization kits for detecting human papillomavirus (HPV) DNA: Oncor Southern blot (SB) (Oncor, Inc., Gaithersburg, MD) 
changes in the methods used to diagnose and manage cervical squamous-cell cancer and its precursors. [1] [2] [3] More recently, molecular, clinicopathologic, viral, and DNA studies have continued to demonstrate similarities between condyloma and cervical intraepithelial neoplasia (CIN) I and between CIN II and CIN III. 4 These similarities are reflected in the Bethesda System for reporting Papanicolaou-stained smears which divides the spectrum of morphologic squamous changes into lowgrade squamous intraepithelial lesion (SIL) (condyloma, CIN I) and high-grade SIL (CIN II,
CIN III).
s There is almost universal agreement that untreated patients with high-grade SIL, especially those with the equivalent of CIN III, are at significantly elevated risk of developing invasive squamous-cell carcinoma over time.
The natural history of low-grade SIL is much more controversial, although a consensus is emerging that most low-grade SILs have a high spontaneous regression rate and are unlikely to progress to invasive cancer. 6 Despite this generally favorable view of low-grade SIL, many published prospective studies document cases of low-grade SIL that have seemingly evolved into high-grade lesions. 7'8 Further confounding the issue is the fact that statements in regard to the natural history of SILs are based on population statistics. Hence, the individual patient and her physician are faced with a probability statement as to what her unique course might be. What is needed is a means to determine which individual low-grade SILs will progress or persist and which will regress.
Although unequivocal evidence establishing that human papillomavirus (HPV) alone is the cause of cervical cancer and its precursor lesions is lacking, the strong association between HPV infection and these disease processes spurs intense efforts to better define the pathogenetic role of HPV. 6'9 Of >70 different types of HPV that infect humans, >20 have a predilection for the genital tract. 10 These can be divided into (Fig. 4) of acquir- The specimens for HPV testing were collected with Christmas-tree cytobrushes at the same time the cytology smears were prepared in order to ensure that the cells were obtained from the same site. Each set of patient samples was combined, mixed, and reallocated to minimize sampling error. The collection of 3 specimens probably accounted for the high number of specimens with blood, i.e., 54/172 cervical specimens. Although Bartholoma et al. 15 utilized bloody specimens in their evaluation of Oncor 32p-labeled probes vs. the Digene ViraPap 32p-labeled probes for HPV screening, they extracted and precipitated the DNA first. This procedure, however, was not endorsed by Digene (personal communication). Retrospectively, 2 visibly bloody SB-positive specimens were tested by DB; both were positive. Due to the current recommendation by many cytopathologists, cytobrushes were used to collect the specimens. Other studies have utilized swabs rather than brushes, which might have accounted for a report of decreased sensitivity of the SB compared with the DB procedure. 16 Of the 109 specimens tested in parallel, 97.3% were concordant for the presence and type of HPV. These findings are considerably higher than those of Burmer et al., 17 Kiviat et al., 18 Although SB is considered the gold standard based on its greater sensitivity and specificity, 21'22 when the results from the Oncor SB using 32p_ labeled probes were compared with the ViraPap DB, it was reported to be less sensitive. 15 
